- Home
- NBIX vs DTM Comparison
NBIX vs DTM Comparison
Compare NBIX & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DTM
- Stock Information
- Founded
- NBIX 1992
- DTM 2021
- Country
- NBIX United States
- DTM United States
- Employees
- NBIX N/A
- DTM N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DTM Oil & Gas Production
- Sector
- NBIX Health Care
- DTM Utilities
- Exchange
- NBIX Nasdaq
- DTM Nasdaq
- Market Cap
- NBIX 12.2B
- DTM 10.8B
- IPO Year
- NBIX 1996
- DTM N/A
- Fundamental
- Price
- NBIX $126.55
- DTM $106.34
- Analyst Decision
- NBIX Strong Buy
- DTM Buy
- Analyst Count
- NBIX 20
- DTM 11
- Target Price
- NBIX $163.20
- DTM $107.64
- AVG Volume (30 Days)
- NBIX 915.2K
- DTM 744.2K
- Earning Date
- NBIX 07-31-2025
- DTM 07-29-2025
- Dividend Yield
- NBIX N/A
- DTM 3.08%
- EPS Growth
- NBIX N/A
- DTM N/A
- EPS
- NBIX 2.96
- DTM 3.68
- Revenue
- NBIX $2,412,600,000.00
- DTM $1,044,000,000.00
- Revenue This Year
- NBIX $16.29
- DTM $24.46
- Revenue Next Year
- NBIX $15.08
- DTM $7.13
- P/E Ratio
- NBIX $42.49
- DTM $28.92
- Revenue Growth
- NBIX 21.73
- DTM 10.83
- 52 Week Low
- NBIX $84.23
- DTM $68.57
- 52 Week High
- NBIX $157.98
- DTM $114.50
- Technical
- Relative Strength Index (RSI)
- NBIX 64.01
- DTM 56.81
- Support Level
- NBIX $122.66
- DTM $103.44
- Resistance Level
- NBIX $126.00
- DTM $107.24
- Average True Range (ATR)
- NBIX 2.55
- DTM 2.18
- MACD
- NBIX -0.33
- DTM -0.35
- Stochastic Oscillator
- NBIX 72.06
- DTM 54.33
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.